Your browser doesn't support javascript.
loading
Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke, A Gabriella; Taube, Shoshana; Smith, Andrew W; Herskovic, Alex; Parashar, Bhupesh; Schwartz, Theodore H.
Afiliação
  • Wernicke AG; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY; Savera Liberty Medical, New York. Electronic address: gabriella.wernicke5@gmail.com.
  • Taube S; Faculty of Medicine, Bruce Rappaport Technion, Haifa, Israel.
  • Smith AW; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY; Mount Sinai School of Medicine, New York, NY.
  • Herskovic A; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY.
  • Parashar B; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY; Department of Radiation Medicine, Zucker School of Medicine of Hofstra University at Northwell, Lake Success, NY.
  • Schwartz TH; Department of Neurological Surgery, Weill Cornell Medical College, New York, NY.
Brachytherapy ; 19(5): 705-712, 2020.
Article em En | MEDLINE | ID: mdl-32928486
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Braquiterapia / Neoplasias Encefálicas / Radioisótopos de Césio / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Braquiterapia / Neoplasias Encefálicas / Radioisótopos de Césio / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article